Ashok Gupta

38.7k total citations · 3 hit papers
252 papers, 6.3k citations indexed

About

Ashok Gupta is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ashok Gupta has authored 252 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Oncology, 74 papers in Surgery and 49 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ashok Gupta's work include Cancer Immunotherapy and Biomarkers (58 papers), Bladder and Urothelial Cancer Treatments (23 papers) and Sinusitis and nasal conditions (15 papers). Ashok Gupta is often cited by papers focused on Cancer Immunotherapy and Biomarkers (58 papers), Bladder and Urothelial Cancer Treatments (23 papers) and Sinusitis and nasal conditions (15 papers). Ashok Gupta collaborates with scholars based in India, United States and United Kingdom. Ashok Gupta's co-authors include Xiaoping Jin, Rachel E. Sanborn, Sabine Rosenberger, Peter H. O’Donnell, Christophe Massard, Scott Antonia, G. Tim Bowden, Rajesh Narwal, Neil H. Segal and Naiyer A. Rizvi and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ashok Gupta

239 papers receiving 6.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma

2017 664 citations Joyce Antal, Xiaoping Jin et al. profile →
Safety and Efficacy of Durvalumab (MEDI4736), an Anti–Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer

2016 661 citations Marlon C. Rebelatto, Xiaoping Jin et al. profile →
Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study

2016 481 citations Ashok Gupta et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Ashok Gupta	3.3k	1.6k	1.3k	1.2k	1.0k	252	6.3k
Yanhong Deng	2.3k 0.7×	1.2k 0.8×	331 0.3×	1.2k 0.9×	1.2k 1.2×	284	5.2k
Yan Li	1.5k 0.5×	976 0.6×	520 0.4×	1.0k 0.8×	1.5k 1.5×	207	4.4k
Jae‐Hyun Park	1.3k 0.4×	623 0.4×	821 0.6×	703 0.6×	2.2k 2.2×	206	4.6k
Barbara Mroczko	1.5k 0.5×	700 0.4×	849 0.7×	460 0.4×	1.5k 1.5×	286	5.2k
Jie Wang	3.8k 1.1×	618 0.4×	801 0.6×	2.9k 2.3×	1.9k 1.9×	346	6.7k
Gang Xu	1.5k 0.5×	1.1k 0.7×	988 0.8×	940 0.8×	2.0k 2.0×	218	8.0k
Kellie A. Charles	4.8k 1.5×	1.0k 0.6×	2.9k 2.3×	1.0k 0.8×	1.8k 1.8×	44	8.3k
Loretta M. Itri	4.0k 1.2×	1.2k 0.8×	1.1k 0.9×	1.5k 1.2×	3.5k 3.5×	91	10.9k
Nicholas Syn	2.0k 0.6×	1.7k 1.1×	584 0.5×	1.9k 1.5×	1.8k 1.8×	225	6.6k
Tingbo Liang	2.6k 0.8×	1.6k 1.0×	1.8k 1.5×	1.1k 0.9×	3.0k 3.0×	306	8.1k

Countries citing papers authored by Ashok Gupta

Since Specialization

Citations

This map shows the geographic impact of Ashok Gupta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashok Gupta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashok Gupta more than expected).

Fields of papers citing papers by Ashok Gupta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashok Gupta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashok Gupta. The network helps show where Ashok Gupta may publish in the future.

Co-authorship network of co-authors of Ashok Gupta

This figure shows the co-authorship network connecting the top 25 collaborators of Ashok Gupta. A scholar is included among the top collaborators of Ashok Gupta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashok Gupta. Ashok Gupta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Gupta, Ashok, et al.. (2025). Limb-Girdle Muscular Dystrophies (LGMD): Clinical features, diagnosis and genetic variability through next generation sequencing. PubMed. 12(1). 100035–100035.

2.

Sun, Kai, et al.. (2024). The potential and pitfalls of using a large language model such as ChatGPT, GPT-4, or LLaMA as a clinical assistant. Journal of the American Medical Informatics Association. 31(9). 1884–1891. 30 indexed citations

3.

Kaur, Ravinder Jeet, et al.. (2023). Prevalence of depression and associated factors among HIV/AIDS patients in India: a systematic review and meta-analysis. Journal of HIV/AIDS & Social Services. 22(3). 128–146.

4.

Sharma, Shringi, Xavier Pépin, Jean Cheung, et al.. (2022). Bioavailability of acalabrutinib suspension delivered via nasogastric tube in the presence or absence of a proton pump inhibitor in healthy subjects. British Journal of Clinical Pharmacology. 88(10). 4573–4584. 3 indexed citations

5.

Zając, M, Jiabu Ye, Pralay Mukhopadhyay, et al.. (2020). Optimal PD-L1–high cutoff for association with overall survival in patients with urothelial cancer treated with durvalumab monotherapy. PLoS ONE. 15(4). e0231936–e0231936. 16 indexed citations

6.

Higgs, Brandon W., Christopher Morehouse, Katie Streicher, et al.. (2018). Interferon Gamma Messenger RNA Signature in Tumor Biopsies Predicts Outcomes in Patients with Non–Small Cell Lung Carcinoma or Urothelial Cancer Treated with Durvalumab. Clinical Cancer Research. 24(16). 3857–3866. 142 indexed citations

7.

Raja, Rajiv, Michael Kuziora, Philip Z. Brohawn, et al.. (2018). Early Reduction in ctDNA Predicts Survival in Patients with Lung and Bladder Cancer Treated with Durvalumab. Clinical Cancer Research. 24(24). 6212–6222. 167 indexed citations

8.

Callahan, Margaret K., Gregg Masters, Christine A. Pratilas, et al.. (2013). Paradoxical Activation of T Cells via Augmented ERK Signaling Mediated by a RAF Inhibitor. Cancer Immunology Research. 2(1). 70–79. 91 indexed citations

9.

Gupta, Ashok, et al.. (2013). Morphometry of the Foramen Magnum: An Important Tool in Sex Determination. 2(4). 88–91. 9 indexed citations

10.

Bharti, Sudhanshu Kumar, et al.. (2012). Antidiabetic effect of aqueous extract of Withania coagulans flower in Poloxamer-407 induced type 2 diabetic rats. Journal of Medicinal Plants Research. 6(45). 5706–5713. 9 indexed citations

11.

Bansal, Sandeep, et al.. (2011). Should Voriconazole be the Primary Therapy for Chronic Invasive Sinus Aspergillosis (CISA)?. Clinical Rhinology An International Journal. 4(1). 21–26. 2 indexed citations

12.

Bansal, Sandeep, et al.. (2011). Should Voriconazole be the Primary Therapy for Chronic Invasive Sinus Aspergillosis (CISA)?. Clinical Rhinology An International Journal. 4(1). 27–37. 2 indexed citations

13.

Gupta, Ashok, et al.. (2010). In-vitro Antioxidant Activity of Aqueous Extract of Physalis minima Linn. Research Journal of Pharmacology and Pharmacodynamics. 2(5). 332–334. 2 indexed citations

14.

Gupta, Ashok, et al.. (2009). Nasopharyngeal Angiofibroma - Staging and Selecting a Surgical Approach: Changing Trends. Clinical Rhinology An International Journal. 2(3). 5–10. 2 indexed citations

15.

Parida, Pradipta Kumar & Ashok Gupta. (2008). Role of spiral computed tomography with 3-dimensional reconstruction in cases with laryngeal stenosis—a radioclinical correlation. American Journal of Otolaryngology. 29(5). 305–311. 5 indexed citations

16.

Sojka, Jane Z., et al.. (2008). An Update on Academic Dishonesty in the College Classroom.. Journal on excellence in college teaching. 19(1). 149–176. 5 indexed citations

17.

Gupta, Ashok, et al.. (2007). Endoscopic Endonasal Management of Pseudotumor Cerebri: Is it Effective?. The Laryngoscope. 117(7). 1138–1142. 15 indexed citations

18.

Gupta, Ashok, et al.. (2007). Cranionasal fistula in pediatric population: Is endonasal endoscopic approach effective?. International Journal of Pediatric Otorhinolaryngology. 71(10). 1537–1541. 10 indexed citations

19.

Gupta, Ashok, et al.. (2005). Is fungal infestation of paranasal sinuses more aggressive in pediatric population?. International Journal of Pediatric Otorhinolaryngology. 70(4). 603–608. 21 indexed citations

20.

Sojka, Jane Z., Ashok Gupta, & Dawn R. Deeter‐Schmelz. (2002). Student and Faculty Perceptions of Student Evaluations of Teaching: A Study of Similarities and Differences. College Teaching. 50(2). 44–49. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact